CN101759698A - 一种恩替卡韦的制备方法 - Google Patents
一种恩替卡韦的制备方法 Download PDFInfo
- Publication number
- CN101759698A CN101759698A CN200910201121A CN200910201121A CN101759698A CN 101759698 A CN101759698 A CN 101759698A CN 200910201121 A CN200910201121 A CN 200910201121A CN 200910201121 A CN200910201121 A CN 200910201121A CN 101759698 A CN101759698 A CN 101759698A
- Authority
- CN
- China
- Prior art keywords
- benzyloxy
- purine
- entecavir
- methoxyl methyl
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009102011211A CN101759698B (zh) | 2009-12-15 | 2009-12-15 | 一种恩替卡韦的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009102011211A CN101759698B (zh) | 2009-12-15 | 2009-12-15 | 一种恩替卡韦的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101759698A true CN101759698A (zh) | 2010-06-30 |
CN101759698B CN101759698B (zh) | 2012-01-18 |
Family
ID=42491093
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009102011211A Active CN101759698B (zh) | 2009-12-15 | 2009-12-15 | 一种恩替卡韦的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101759698B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106749249A (zh) * | 2017-01-13 | 2017-05-31 | 信泰制药(苏州)有限公司 | 恩替卡韦中间体的晶型 |
CN106749252A (zh) * | 2017-01-23 | 2017-05-31 | 山东鲁抗医药股份有限公司 | 一种恩替卡韦中间体n8的提纯方法 |
CN112812029A (zh) * | 2021-01-23 | 2021-05-18 | 杭州臻挚生物科技有限公司 | 苯巴豆酸酯类化合物的制备方法 |
CN114539098A (zh) * | 2022-02-26 | 2022-05-27 | 青岛大学 | 一种双功能hdac6抑制剂、合成方法及应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5206244A (en) * | 1990-10-18 | 1993-04-27 | E. R. Squibb & Sons, Inc. | Hydroxymethyl (methylenecyclopentyl) purines and pyrimidines |
-
2009
- 2009-12-15 CN CN2009102011211A patent/CN101759698B/zh active Active
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106749249A (zh) * | 2017-01-13 | 2017-05-31 | 信泰制药(苏州)有限公司 | 恩替卡韦中间体的晶型 |
CN106749252A (zh) * | 2017-01-23 | 2017-05-31 | 山东鲁抗医药股份有限公司 | 一种恩替卡韦中间体n8的提纯方法 |
CN112812029A (zh) * | 2021-01-23 | 2021-05-18 | 杭州臻挚生物科技有限公司 | 苯巴豆酸酯类化合物的制备方法 |
CN112812029B (zh) * | 2021-01-23 | 2023-08-15 | 台州臻挚生物科技有限公司 | 苯巴豆酸酯类化合物的制备方法 |
CN114539098A (zh) * | 2022-02-26 | 2022-05-27 | 青岛大学 | 一种双功能hdac6抑制剂、合成方法及应用 |
CN114539098B (zh) * | 2022-02-26 | 2024-05-24 | 青岛大学 | 一种双功能hdac6抑制剂、合成方法及应用 |
Also Published As
Publication number | Publication date |
---|---|
CN101759698B (zh) | 2012-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108947891B (zh) | 利用三光气安全制备匹莫范色林及其酒石酸盐的方法 | |
CN101759698B (zh) | 一种恩替卡韦的制备方法 | |
CN111233930B (zh) | 一种瑞德西韦的制备方法 | |
CN108794351B (zh) | 一种匹莫范色林关键中间体的制备方法 | |
CN102952135B (zh) | 一种乙肝药物恩替卡韦的合成方法 | |
CN102617678A (zh) | 盐酸吉西他滨的制备方法 | |
CN105985225A (zh) | 一种lcz-696及其中间体的制备方法 | |
CN103351372A (zh) | 替卡格雷中间体的制备方法 | |
CN102060876B (zh) | 一种替诺福韦制备方法 | |
CN113527303A (zh) | 一种瑞德西韦母核中间体的制备工艺 | |
CN101891741B (zh) | 抗病毒药恩替卡韦的新合成工艺 | |
CN104151359A (zh) | 喹唑啉类化合物及其制备方法和在制备酪氨酸激酶抑制剂中的应用 | |
CN106068271A (zh) | 2`‑取代‑2,2`‑脱水尿苷或2`‑取代‑2,2`‑脱水胞苷化合物及其制备方法和用途 | |
CN103012290B (zh) | 一种高纯度吉非替尼的制备方法 | |
CN105968091A (zh) | 一种制备治疗ii型糖尿病药物阿格列汀的方法 | |
CN103333117B (zh) | 一种4[(4-氯-2-嘧啶基)氨基]苯腈的制备方法 | |
CN111943937A (zh) | 三苯基坎地沙坦的合成方法 | |
CN104744336B (zh) | 一种西洛多辛中间体及其制备方法,以及用该中间体制备西洛多辛的方法 | |
CN103694279B (zh) | 一种制备2-脱氧-l-核糖的方法 | |
CN106749098B (zh) | 一种以氧气为氧化剂制备盐酸二氧丙嗪的制备方法 | |
CN111978328B (zh) | 一种替格瑞洛的合成方法 | |
CN104109185B (zh) | 一种醋酸阿比特龙的制备方法 | |
WO2021109099A1 (zh) | 利用微通道连续流反应器制备 5- 单硝酸异山梨酯的方法 | |
CN101792477A (zh) | 具抗癌活性的乙酰熊果酰三乙醇胺单酯及其制备方法 | |
CN104926806B (zh) | 一种合成拉米夫定中间体的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI ZHONGXI SUNVE PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: SHANGHAI PHARMACEUTICAL (GROUP) CO., LTD. Effective date: 20120613 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 201203 PUDONG NEW AREA, SHANGHAI TO: 200331 PUTUO, SHANGHAI |
|
TR01 | Transfer of patent right |
Effective date of registration: 20120613 Address after: 200331 No. 50, Yongdeng Road, Shanghai, Putuo District Patentee after: Shanghai Zhongxi Sunve Pharmaceutical Co., Ltd. Address before: 201203 Pudong New Area Zhangjiang Road, Shanghai, No. 92 Patentee before: Shanghai Pharmaceuticals Holding Co., Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI ZHONGXI SUNVE PHARMACEUTICAL CO., LTD. Effective date: 20120918 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20120918 Address after: 201203 Pudong New Area Zhangjiang Road, Shanghai, No. 92 Patentee after: Shanghai Pharmaceuticals Holding Co., Ltd. Patentee after: Shanghai Zhongxi Sunve Pharmaceutical Co., Ltd. Address before: 201203 Pudong New Area Zhangjiang Road, Shanghai, No. 92 Patentee before: Shanghai Pharmaceuticals Holding Co., Ltd. |